Kennedy did not read about regulatory capture in a political science textbook. He litigated it.

Starting in 1987, Kennedy served as senior attorney — eventually chief litigator — for Riverkeeper, the organization protecting the Hudson River watershed. He sued polluters. He won. And in the course of winning, he documented the mechanism: chemical companies funding the research that exonerated them, agency officials rotating between the EPA and the industries they regulated, science that contradicted corporate interests quietly disappearing from the public record.

This is not conspiracy thinking. It is administrative law. The phenomenon has a name, a literature, and a Nobel laureate — George Stigler theorized regulatory capture in 1971. Kennedy's contribution was not the theory. It was the courtroom receipts.

The Riverkeeper model he helped establish spread to over 300 watershed protection organizations worldwide. Environmental law scholars treat his litigation record as foundational. This is the man that critics of his later work must contend with — not a credulous outsider, but someone with a demonstrated capacity to identify institutional corruption in one regulatory domain and prove it in court.

The question his career raises is not whether he is right about everything. It is whether the methodology he developed in environmental law can travel. When chemical executives fund the studies that determine chemical safety limits, that is corrupt. When pharmaceutical companies fund the studies that determine drug approval — the explicit structure created by the Prescription Drug User Fee Act of 1992 — is the mechanism different, or only the industry?

Kennedy says it is not different. His critics say the analogy breaks down. Neither side has fully answered the other. That gap is where his career lives.

Kennedy's position on vaccines is consistently misrepresented in both directions.

He is not anti-vaccine in the categorical sense his opponents describe. He has repeatedly stated that he is not opposed to vaccines as a category. His stated position is structural: that the safety studies underpinning vaccine approval are compromised by conflicts of interest, that the regulatory process has been captured by the industry it oversees, and that independent safety science has been systematically suppressed or defunded.

This is meaningfully different from claiming vaccines cause autism. He has made that specific claim — most prominently about thimerosal, a mercury-based preservative used in some vaccines. That claim is not supported by the weight of scientific evidence. The 2005 Rolling Stone article in which he made it most forcefully, "Deadly Immunity," was subsequently and substantially corrected by the magazine. It remains his most prominent evidentiary failure and the most frequently cited evidence that his methodology breaks down under pressure.

Here is the problem with stopping there.

The institutional critique and the specific empirical claim are two different things. Kennedy is wrong, or at minimum badly outrunning the evidence, on the thimerosal-autism hypothesis. His critics are right about that. But the critique of institutional process — that industry funding distorts research outcomes, that the FDA's drug review mechanism creates structural conflicts — is not refuted by pointing to his worst paper. That critique is published in peer-reviewed journals, documented in congressional testimony, and replicated across multiple independent research groups.

Industry-funded trials produce favorable results at rates significantly higher than independently funded trials. This is not Kennedy's claim. It is published science. It has been replicated. It does not go away because Kennedy cited it badly in one article.

The conflation of his weakest empirical claims with his strongest institutional arguments is itself worth examining. It is a coherent rhetorical strategy. It is not a coherent epistemological one.

Something happened to American children's health between 1980 and now.

Autism diagnosis rates have risen from roughly 1 in 10,000 in the early 1980s to approximately 1 in 36 by 2023. ADHD diagnoses, childhood autoimmune disorders, food allergies, and anxiety disorders have followed similar trajectories. These are not small statistical fluctuations. They are population-level shifts.

The scientific establishment's answers — improved diagnostic criteria, broader definitions, increased awareness — account for some of the increase. They do not account for all of it. The honest position, shared by researchers who are not Kennedy allies, is that the causes of these trends are not fully understood.

Kennedy's synthesis points to a cluster of environmental factors: pesticide exposure (particularly glyphosate), microplastics accumulation, disruption of the gut microbiome through ultra-processed food, altered dietary fat profiles since the introduction of seed oils, and vaccine schedule interactions. He draws on real researchers — many of them credentialed and published — when making these arguments.

Where he outruns the evidence is at the level of causal certainty. The association between these environmental factors and chronic illness outcomes is real and being actively studied. The specific causal chains Kennedy describes with confidence are, in many cases, still contested at the level of mechanism. He presents hypotheses as conclusions. His critics present conclusions as hypotheses. Neither posture is honest.

What Kennedy gets right, and what gets obscured in the effort to discredit him, is the legitimacy of the question itself. Rising childhood chronic illness is real. Demanding a better explanation than "we're just diagnosing it more" is not irrational. The quality of his specific answers varies. The validity of the question does not.

The word capture in regulatory capture is precise. It does not mean corruption in the crude sense — envelopes of cash, explicit deals. It means a regulatory body, over time, comes to define its mission in terms the regulated industry finds acceptable. It begins to see the world through the industry's categories. Officials who antagonize industry do not advance. Officials who understand industry's needs do.

This process does not require conspiracy. It requires incentives, time, and the ordinary human tendency to favor people who treat you well. Stigler's 1971 paper described the mechanism. Decades of political science literature have refined it. Kennedy did not invent it. He applied it.

The question is whether his application is rigorous or selective. His environmental record suggests rigor. His vaccine record suggests he sometimes reaches his conclusion before completing his evidence. Both can be true simultaneously. They are.

Kennedy carries the most mythologized surname in American political history.

His grandfather founded a banking dynasty. His uncle was president of the United States. His father was assassinated in 1968, when Kennedy was fourteen, running for that same office. He grew up inside the American establishment — not adjacent to it, inside it. Harvard. University of Virginia School of Law. The family compound. The social world where Supreme Court justices and cabinet secretaries are dinner guests.

He became, from inside that world, one of its most persistent critics.

His family has publicly distanced itself from his public health positions. In 2023, more than sixty Kennedy family members signed an open letter urging voters not to support his presidential campaign, citing his vaccine positions specifically. His niece, Caroline Kennedy Schlossberg, called his views dangerous. These are not strangers. These are people who share his blood and his grief and the weight of the name.

This is a specific kind of institutional heresy — not the dissent of someone who was never let in, but the dissent of someone who inherited the keys and handed them back. It reads differently. It costs differently. The social and familial capital Kennedy spent to sustain his positions over three decades is not trivial, and it is not the behavior of someone performing dissent for an audience.

That does not make him right. People who pay enormous personal costs to be wrong are a well-documented historical category. But it does change the interpretive frame. He is not a grifter who found a profitable lane in anti-establishment rhetoric. The lane cost him.

His presidential campaign in 2023 and 2024 tested his actual public support. He polled as high as 22% in national surveys as an independent — extraordinary for a third-party candidate, almost entirely unsustainable. He suspended the campaign and endorsed Donald Trump. That endorsement troubled many of his supporters who had followed his critique of institutional power regardless of party. It remains unresolved as evidence of his character and judgment.

Public trust in American medical institutions did not collapse because of Robert F. Kennedy Jr.

The collapse began before he became a national figure. Trust in the CDC, FDA, and NIH has declined steadily since at least the 1990s. The opioid epidemic — in which FDA-approved drugs, promoted by manufacturer-funded research, with regulatory officials rotating through industry jobs, killed hundreds of thousands of Americans — preceded Kennedy's national prominence and validated every structural argument he had been making.

When official institutions assured the public that OxyContin was not addictive, they were wrong. When those same institutional voices then assured the public that other concerns were unfounded conspiracy theories, a significant portion of the public had already learned not to listen. Kennedy did not create that erosion. He walked into a space that was already empty and spoke into it.

This is the most important and least examined dimension of his influence.

The institutional trust crisis is real and documented. Gallup polling shows confidence in medical institutions at historic lows. The people who find Kennedy's arguments compelling are not primarily credulous or irrational. Many of them are people who watched official science fail them or people they loved — through the opioid crisis, through SSRI prescribing practices in children, through the Vioxx scandal, through a hundred smaller institutional failures that never made national headlines but left individual families with permanent damage.

Kennedy speaks to those people. His specific claims about those specific failures vary in accuracy. His underlying argument — that the institutional structure produces incentives for failure and suppresses accountability — is not the reason those people distrust institutions. It is a framework that makes sense of something they already knew from experience.

The question is what happens when that hunger for a different account grows faster than any single person can responsibly feed it. Kennedy oversimplifies. He overstates. He draws certain conclusions from uncertain evidence. But the hunger he feeds would exist without him, and it will outlast him.

In 2025, with Senate confirmation, he became Secretary of Health and Human Services — administrative authority over the FDA, the NIH, and the CDC. The agencies he spent thirty years indicting are now his agencies to run.

If his critique was accurate, he has a historic opportunity to document what he found and dismantle it. If his critique was selective or distorted, that will become visible under the friction of administrative reality. Both outcomes will be informative. Neither will be comfortable.

The Kennedy question is not, at its root, a political question. It is an epistemological one.

How do you evaluate claims made against the institutions that produce the evidence? If the critique of regulatory capture is correct, the captured institution's refutation of that critique is not independent evidence. It is the testimony of the accused. But if every institutional refutation can be dismissed as captured, no evidence can constrain any claim. That is a path to unfalsifiable thinking and the end of shared reality.

Kennedy has not resolved this problem. Neither have his critics. His critics dismiss his arguments by citing the consensus of the institutions he indicts — which begs the question. His supporters treat every piece of contradictory evidence as further proof of suppression — which is not epistemology, it is a closed loop.

The honest position requires holding two things simultaneously. Institutional corruption is real, documented, and consequential. Specific claims require specific evidence, and the evidence for some of Kennedy's specific claims is weak. These two facts do not cancel each other out. They coexist.

What Kennedy's career actually demonstrates is the cost and shape of sustained dissent inside a credentialed world. He had the credentials to enter that world's arguments on its own terms. He used them to make arguments the world found threatening. He was marginalized, corrected, mocked, and in some cases rightly so. He continued anyway.

Whether history vindicates him partially, fully, or not at all is unknown and will remain unknown until the administrative experiment he is now running produces data. What is already knowable is the structure of his career: a man who developed a working methodology in one domain, transferred it to another, overapplied it in some instances, identified real problems in others, and paid sustained personal costs for refusing to stop.

That is not the biography of a crank. It is not the biography of a prophet. It is the biography of a specific kind of institutional heretic — one whose accuracy and whose errors are both, in some ways, products of the same relentless methodology.